Conditions of MTC in sufferers dealt with with liraglutide, One more GLP-one receptor agonist, are already documented in the postmarketing time period; the data in these stories are insufficient to ascertain or exclude a causal partnership involving MTC and GLP-one receptor agonist use in humans. changes in eyesight. Tell your wellbeing care co